Arquivos de Asma, Alergia e Imunologia
https://www.aaai-asbai.org.br/article/doi/10.5935/2526-5393.20250034
Arquivos de Asma, Alergia e Imunologia
Comunicação Clínica e Experimental

Dermatose eosinofílica paraneoplásica simulando prurigo nodular como manifestação inicial de linfoma de células B em idoso

Paraneoplastic eosinophilic dermatosis mimicking prurigo nodularis as the initial manifestation of B-cell lymphoma in an older adult

Bruno Emanuel Carvalho Oliveira; Mirella Dantas Fulco; Maíra Medeiros Pacheco de-Andrade

Downloads: 0
Views: 16

Resumo

O prurido crônico é uma queixa prevalente entre idosos e, quando refratário ao tratamento, pode indicar doenças sistêmicas subjacentes, incluindo neoplasias hematológicas. Este artigo descreve o caso de um paciente de 81 anos com prurido intenso de seis meses de duração, acompanhado de lesões nodulares disseminadas e eosinofilia periférica. A biópsia cutânea inicial foi compatível com prurigo nodular, mas a ausência de melhora clínica levou à realização de nova biópsia associada à imunofenotipagem, que revelou infiltrado dérmico com predomínio de eosinófilos e presença de população clonal de linfócitos B com forte expressão de CD20, confirmando linfoma de células B maduras. O diagnóstico final foi de dermatose eosinofílica como manifestação paraneoplásica do linfoma. A discussão aborda a fisiopatologia multifatorial do prurido senil, incluindo alterações na barreira cutânea, disfunções imunológicas com polarização Th2 e papel inflamatório dos eosinófilos, que podem atuar como células apresentadoras de antígenos não convencionais e mediadores teciduais. As dermatoses eosinofílicas paraneoplásicas, embora raras e frequentemente subdiagnosticadas, são manifestações clínicas importantes em hematopatias malignas e podem simular dermatoses benignas como o prurigo nodular. O reconhecimento dessas apresentações atípicas é essencial para o diagnóstico precoce. Conclui-se que quadros de prurido crônico refratário em idosos devem ser abordados com alta suspeição clínica e investigação ampliada. A atuação conjunta de especialistas em alergologia, dermatologia e hematologia foi decisiva para a elucidação diagnóstica e definição terapêutica. O diagnóstico precoce de síndromes paraneoplásicas pode m

Palavras-chave

Prurido, linfoma de células B, eosinofilia.

Abstract

Chronic pruritus is a common complaint among older adults and, when refractory to treatment, may indicate underlying systemic diseases, including hematologic neoplasms. This article presents the case of an 81-year-old patient with intense pruritus lasting 6 months, accompanied by disseminated nodular lesions and peripheral eosinophilia. The initial skin biopsy was consistent with prurigo nodularis; however, the absence of clinical improvement prompted a repeat biopsy with immunophenotyping, which revealed a dermal infiltrate predominantly composed of eosinophils and a clonal population of B lymphocytes with strong CD20 expression, confirming mature B-cell lymphoma. The final diagnosis was eosinophilic dermatosis as a paraneoplastic manifestation of lymphoma. The discussion addresses the multifactorial pathophysiology of senile pruritus, including impairment of the skin barrier, immune dysregulation with Th2 polarization, and the inflammatory role of eosinophils, which may act as unconventional antigen-presenting cells and tissue mediators. Paraneoplastic eosinophilic dermatoses, although rare and often underdiagnosed, are important clinical manifestations of malignant hematologic disorders and may mimic benign dermatoses such as prurigo nodularis. Recognition of these atypical presentations is essential for early diagnosis. It can be concluded that cases of chronic refractory pruritus in older adults should prompt a high index of clinical suspicion and a comprehensive diagnostic workup. Multidisciplinary collaboration among allergists, dermatologists, and hematologists was crucial for diagnostic clarification and treatment decision-making. Early diagnosis of paraneoplastic syndromes may alter the clinical course and improve patient prognosis.

Keywords

Pruritus, B-cell lymphoma, eosinophilia.

Referências

1. Chung BY, Um JY, Kim JC, Kang SY, Park CW, Kim HO. Pathophysiology and treatment of pruritus in elderly. Int J Mol Sci. 2020;22(1):174.

2. Silva JA, Mesquita KC, Igreja AC, Lucas ICRN, Freitas AF, Oliveira SM, et al. Paraneoplastic cutaneous manifestations: concepts and updates. An Bras Dermatol. 2013;88(1):9-22.

3. Dalgard F, Dawn A, Yosipovich G. Are itch and chronic pain associated in adults? Results of a large population survey in Norway. Dermatology. 2007;214:305-9.

4. Criado PR, Ianhez M, Criado RFJ, Nakano J, Lorenzini D, Miot HA. Prurigo: review of its pathogenesis, diagnosis, and treatment. An Bras Dermatol. 2024;99:706-20.

5. Ramos-E-Silva M, Carvalho JC, Carneiro SC. Cutaneous paraneoplasia. Clin Dermatol. 2011;29:541-7.

6. Pipkin CA, Lio PA. Cutaneous manifestations of internal malignancies: an overview. Dermatol Clin. 2008;26:1-15.

7. Sneddon IB. Cutaneous manifestations of visceral malignancy. Postgrad Med J. 1970;46:678-85. Referências

8. Poole S, Fenske NA. Cutaneous markers of internal malignancy. I. Malignant involvement of the skin and the genodermatoses. J Am Acad Dermatol. 1993;28:1-13.

9. Ortega-Loayza AG, Ramos W, Gutierrez EL, Paz PC, Bobbio L, Galarza C. Cutaneous manifestations of internal malignancies in a tertiary health care hospital of a developing country. An Bras Dermatol. 2010;85:736-42.

10. Sato-Sano M, Teixeira SP, Vargas JC, Baiocchi OCCG, Enokihara MMSES, Gomes EE, et al. Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy. J Dermatol. 2019;46(7):618-21.

11. Maglie R, Genovese G, Solimani F, Guglielmo A, Pileri A, Portelli F, et al. Immune-mediated dermatoses in patients with haematological malignancies: a comprehensive review. Am J Clin Dermatol. 2020;21:833-54.

12. Rodríguez-Lojo R, Almagro M, Piñeyro F, Pérez-Varela L, FernándezJorge B, Del Pozo J, et al. Eosinophilic panniculitis and insect bite-like eruption in a patient with chronic lymphocytic leukaemia: a spectrum of the same entity. Dermatol Res Pract. 2010;2010:263827.

13. Peckruhn M, Elsner P, Tittelbach J. Eosinophilic dermatoses. J Dtsch Dermatol Ges. 2019;17(10):1039-51.

14. Farber MJ, La Forgia S, Sahu J, Lee JB. Eosinophilic dermatosis of hematologic malignancy. J Cutan Pathol. 2012;39(7):690-5.

15. Lucas-Truyols S, Rodrigo-Nicolás B, Lloret-Ruiz C, QuecedoEstébanez E. Dermatosis eosinofílicas asociadas a procesos hematológicos. Actas Dermosifiliogr. 2017;108:e39-44.

16. Jin A, Pousti BT, Savage KT, Mollanazar NK, Lee JB, Hsu S. Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia. JAAD Case Rep. 2019;5(9):815-7.

17. de Souza PK, Amorim RO, Sousa LS, Batista MD. Dermatological manifestations of hematologic neoplasms. Part II: nonspecific skin lesions/paraneoplastic diseases. An Bras Dermatol. 2023;98(2):141‑58.

18. Nunes M de G, Pierro APS de M, Coutinho MFV, Morais JCO de, Carneiro SC da S, Azulay DR. Linfoma cutâneo de células B: relato de caso. Anais Brasileiros de Dermatologia. 2004 Dec;79(6):715-20.

19. Sampaio SAP, Rivitti EA. Leucemias, Linfomas e Pseudolinfomas. In: Dermatologia. 2ª ed. São Paulo: Artes Médicas; 2000. p.887-913.

20. Odom RB, James WD, Berger TG. Cutaneous Lymphoid Hyperplasia, Cutaneous T-Cell Lymphoma, Other Malignant Lymphomas, and Allied Diseases. In: Andrews Diseases of the Skin, Clinical Dermatology. 9ª ed. Philadelphia: W.B. Saunders Company; 2000. p.918-42.

21. Burg G, Kempf W, Haeffner AC. Cutaneous lymphomas. Curr Probl Dermatol. 1997; 9:137-204.


Submetido em:
24/05/2025

Aceito em:
07/08/2025

69ea3d1ba9539525202e28b2 aaai Articles
Links & Downloads

Arq Asma Alerg Imunol

Share this page
Page Sections